Abstract

Carriers of pathogenic variants causing hereditary breast and ovarian cancer (HBOC) are confronted with a high risk to develop malignancies early in life. The present study aimed to determine the type of psychological distress and coping ability in women with a suspicion of HBOC. In particular, we were interested if the self-assessed genetic risk had an influence on health concerns and coping ability. Using a questionnaire established by the German HBOC Consortium, we investigated 255 women with breast cancer and 161 healthy women before they were seen for genetic counseling. The group of healthy women was divided into groups of high and low self-assessed risk. In our study, healthy women with a high self-assessed risk stated the highest stress level and worries about their health and future. A quarter of the women requested psychological support. Overall, only few women (4–11%) stated that they did not feel able to cope with the genetic test result. More women (11–23%, highest values in the low-risk group) worried about the coping ability of relatives. The results of our exploratory study demonstrate that the women, who presented at the Department of Human Genetics, Hanover Medical School, Germany were aware of their genetic risk and had severe concerns about their future health, but still felt able to cope with the genetic test result.

Highlights

  • Breast and ovarian cancers are among the most common cancers in women in the developed world [1]

  • This study provides valuable insights into psychological distress of women with suspected hereditary breast and ovarian cancer (HBOC), who presented for genetic counseling and testing at the Department of Human Genetics at the Hanover Medical School, the limitations of the study need to be considered

  • This study demonstrates that women undergoing genetic counseling to seek advice regarding hereditary breast and ovarian cancer, whether diseased from breast cancer or not, present with a variety of worries, about their health and future

Read more

Summary

Introduction

Breast and ovarian cancers are among the most common cancers in women in the developed world [1]. Women carrying a pathogenic variant are at high risk of developing breast or ovarian cancer. The lifetime risks for carriers of a BRCA1-pathogenic variant range from 65% to 79% for breast cancer and from 36% to 53% for ovarian cancer [3]. In families with HBOC, usually several close relatives disease, often early in life, or even die from breast and ovarian cancer [4]. These individual and family characteristics can be used to assess the personal risk to carry a pathogenic variant, the need for intensified screening, and a potential offer of risk-reducing surgery.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.